Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer.
about
Development of nanoscale approaches for ovarian cancer therapeutics and diagnosticsExpression and Function of CD44 in Epithelial Ovarian CarcinomaTargeting hyaluronic acid family for cancer chemoprevention and therapy.The Role of CD44 in Disease Pathophysiology and Targeted Treatment.Polymeric 3D nano-architectures for transport and delivery of therapeutically relevant biomacromolecules.Efficacy of piroxicam plus cisplatin-loaded PLGA nanoparticles in inducing apoptosis in mesothelioma cells.Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells.The biology and role of CD44 in cancer progression: therapeutic implications.
P2860
Q30421664-4D0CD0C2-043A-4159-87B2-7B39838CEA32Q36409587-6AAE5E7A-5575-475A-8E0C-714226251CCCQ38235792-FDC92025-EECB-4B68-9AA5-8046D41620A8Q38466771-D8B40C25-70A6-4437-8D01-2FDE33DC9D25Q38555019-0361CB52-D3DC-4957-A621-5D609FE61A68Q38968761-3D5A2D85-B65B-4F8D-824A-AA086A291D95Q41260008-BEB595AE-E438-453A-9097-5937B79CDBBBQ54110894-E81EA4E1-D085-48FA-AC8E-01C3091C1638
P2860
Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Administration of PLGA nanopar ...... ffects against ovarian cancer.
@en
Administration of PLGA nanopar ...... ffects against ovarian cancer.
@nl
type
label
Administration of PLGA nanopar ...... ffects against ovarian cancer.
@en
Administration of PLGA nanopar ...... ffects against ovarian cancer.
@nl
prefLabel
Administration of PLGA nanopar ...... ffects against ovarian cancer.
@en
Administration of PLGA nanopar ...... ffects against ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
Administration of PLGA nanopar ...... ffects against ovarian cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2013.12
P577
2013-03-15T00:00:00Z
P5875
P6179
1040368345